Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
02/01/2012 | EP2412817A1 Method for removing viruses in high-concentration monoclonal antibody solution |
02/01/2012 | EP2412816A2 Process for improved protein expression by strain engineering |
02/01/2012 | EP2412815A1 N-glycosylation in transformed Phaeodactylum tricornutum |
02/01/2012 | EP2412809A1 Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand |
02/01/2012 | EP2412808A1 Lh-type bispecific antibody |
02/01/2012 | EP2412729A2 Peptide purification by means of hard metal ion affinity chromatography |
02/01/2012 | EP2412722A1 A method for identification, isolation and production of antigens to a specific pathogen |
02/01/2012 | EP2412384A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
02/01/2012 | EP2412242A2 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
02/01/2012 | EP2411526A2 Ganglioside biosynthesis modulators |
02/01/2012 | EP2411050A2 Antibody constant domain regions and uses thereof |
02/01/2012 | EP1978994B1 Bmp-7 variant compositions, methods and uses |
02/01/2012 | EP1472353B1 Group b streptococcus antigen |
02/01/2012 | EP0998486B2 Protein recovery by chromatography followed by filtration upon a charged layer |
02/01/2012 | CN1867581B Il-21衍生物 Il-21 derivatives |
02/01/2012 | CN102341497A Thermotolerant transglutaminase originating in actinomyces |
02/01/2012 | CN102337318A Gingko antioxidant active peptide and preparation method thereof |
02/01/2012 | CN102337317A Metarrhizium anisopliae preparation and application thereof in control of plant parasitic wireworms |
02/01/2012 | CN102337286A Improved bacterial host cell for the direct expression of peptides |
02/01/2012 | CN102337243A Cell culture improvements |
02/01/2012 | CN102337241A Improved bacterial host cell for the direct expression of peptides |
02/01/2012 | CN102337223A Penicillium chrysogenum antifungal protein Pc-Arctin and preparation method thereof |
02/01/2012 | CN102336835A Fusion protein of interleukin-3 derived fragment and purpose thereof |
02/01/2012 | CN102336822A Truncate human papilloma virus (HPV) 58 type L1 protein |
02/01/2012 | CN102336817A Separation method of echinocandin B mother nucleus |
02/01/2012 | CN102336806A Angiotensin converting enzyme (ACE) inhibitor |
02/01/2012 | CN101838325B 猪用抗原呈递蛋白及其编码基因和应用 Pig protein and the gene encoding the antigen-presenting and applications |
02/01/2012 | CN101696233B 蛋清蛋白血管紧张素转化酶抑制肽及其制备 Egg white protein angiotensin converting enzyme inhibitory peptides and preparation |
02/01/2012 | CN101591690B 一种重组人干扰素α2b的高密度发酵方法 A high density fermentation process of recombinant human interferon α2b |
02/01/2012 | CN101358225B 高唾液酸含量的免疫球蛋白抗体的制备方法与应用 Preparation of high sialic acid content and application of immunoglobulin antibody |
01/31/2012 | US8106176 Matrix metalloproteinase 11 vaccine |
01/31/2012 | US8106171 Nel-related type 1 polypeptide |
01/31/2012 | US8106160 N-terminal modified interferon-alpha |
01/31/2012 | US8106156 PRO1120 polypeptides |
01/31/2012 | US8106010 Variants of pigment epithelium derived factor and uses thereof |
01/31/2012 | US8105830 Polyspecific binding molecules and uses thereof |
01/31/2012 | US8105825 Multiple inducible gene regulation system |
01/31/2012 | US8105815 Asparaginase and its use in food production |
01/31/2012 | US8105804 Polynucleotides encoding novel PCSK9 variants |
01/31/2012 | US8105803 Phosphatases involved in the regulation of cardiomyocyte differentiation |
01/31/2012 | US8105802 Method of producing microbial transglutaminase |
01/31/2012 | US8105799 Using transforming growth factor-beta -activated kinase-1 (TAK-1) and TAK1 binding protein 1(TAB-1) as evaluative tool in detection of modulators of interleukin and tumor necrosis factor activities |
01/31/2012 | US8105792 Epithelial sodium channel (ENaC) cloned from human kidney cDNA library; modulates salty taste in humans |
01/31/2012 | US8105774 Using peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PGC-1Beta) as tool to identify modulators for treatment of free radical associated disorders |
01/31/2012 | US8105610 Method of making novel erythrovirus V9 VP2 capsid polypeptides |
01/31/2012 | US8105596 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
01/31/2012 | US8105595 Methods of using neutralizing anti-TLR4/MD2 antibodies |
01/31/2012 | US8105587 Methods of treating arthritis using IL-1β binding molecules |
01/31/2012 | US8105586 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
01/31/2012 | US8105574 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
01/31/2012 | US8104533 Spray nozzle apparatus and method of use |
01/31/2012 | CA2443947C Recombinant p. vivax merozoite protein-1 p42 vaccine |
01/31/2012 | CA2339889C Identification of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
01/31/2012 | CA2285672C Purified telomerase |
01/31/2012 | CA2226087C Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
01/30/2012 | CA2747462A1 Systems and methods for the secretion of recombinant proteins in gram negative bacteria |
01/26/2012 | WO2012012708A1 Induced pluripotent stem cells |
01/26/2012 | WO2012012462A2 Plant-based production of heterologous proteins |
01/26/2012 | WO2012011396A1 Transgenic rice plant capable of expressing nanoantibody |
01/26/2012 | WO2012009790A1 Cross-protective pathogen protection, methods and compositions thereof |
01/26/2012 | WO2011105841A9 Recombinant expression vector for expressing brazzein, and novel multiple mutation brazzein variant having greater sweetness |
01/26/2012 | US20120023623 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
01/26/2012 | US20120023614 Environmental stress-inducible 557 promoter isolated from rice and uses thereof |
01/26/2012 | US20120022238 Effector function enhanced recombinant antibody composition |
01/26/2012 | US20120022236 Recombinant Anti-VLA4 Antibody Molecules |
01/26/2012 | US20120022232 Cells for increased protein expression comprising one or more release factors and methods of use |
01/26/2012 | US20120021950 Expression Vector |
01/26/2012 | US20120021459 Feed media |
01/26/2012 | US20120021458 Thermotolerant transglutaminase originating in actinomyces |
01/26/2012 | US20120021457 Protein concentrates and isolates, and processes for the production thereof from macroalgae and/or microalgae |
01/26/2012 | US20120021004 Medium and method of deriving and using a mutated bacteria strain |
01/26/2012 | US20120020988 Antibodies specifically binding to human TSLPR and methods of use |
01/26/2012 | US20120020985 Antibodies against il-17br |
01/26/2012 | US20120020980 High affinity human antibodies to human cytomegalovirus (cmv) gb protein |
01/26/2012 | US20120020979 METHODS FOR TREATING IgE-MEDIATED DISORDER |
01/26/2012 | US20120020978 Antibodies against fatty acid synthase |
01/26/2012 | US20120020975 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
01/26/2012 | US20120020973 Chimeric ospa genes, proteins, and methods of use thereof |
01/26/2012 | US20120020972 Antibodies relating to pivka-ii and uses thereof |
01/26/2012 | US20120020971 Antibodies useful in passive influenza immunization |
01/26/2012 | US20120020966 Multispecific antibody targeting and multivalency through modular recognition domains |
01/26/2012 | US20120020965 Molecules that bind CD180, compositions and methods of use |
01/26/2012 | US20120020952 Methods for producing mixtures of antibodies |
01/26/2012 | US20120020940 Antimicrobial peptides |
01/26/2012 | US20120020916 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
01/26/2012 | CA2806250A1 Cross-protective pathogen protection, methods and compositions thereof |
01/26/2012 | CA2805799A1 Plant-based production of heterologous proteins |
01/25/2012 | EP2410337A1 Method for measuring -glucan, and -glucan-binding protein for use in the method |
01/25/2012 | EP2410331A1 Aminoacyl-tRNA synthetase for aminoacylation tRNA with unnatural amino acids |
01/25/2012 | EP2409991A1 Antibody constant region variant |
01/25/2012 | EP2409990A1 Antibody constant region variant |
01/25/2012 | EP2409981A1 Glucanases, nucleic acids encoding them and methods for making and using them |
01/25/2012 | EP2408926A2 Production of recombinant proteins in ciliates and uses thereof |
01/25/2012 | EP2408911A1 Polypeptide expression in ciliates |
01/25/2012 | EP2408910A2 Chrysosporium lucknowense protein production system |
01/25/2012 | EP2408814A2 Carrier immunoglobulins and uses thereof |
01/25/2012 | EP1984013B1 Modifications of cst-ii for increased protein expression |
01/25/2012 | EP1613735B1 Expanding the eukaryotic genetic code |
01/25/2012 | EP1545613B9 Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
01/25/2012 | EP1440157B1 Methods and means for producing proteins with predetermined post-translational modifications |